Gaudium IVF IPO GMP Signals 11% Listing Gain; Check Key Details

New Delhi-based Gaudium IVF and Women Health Ltd. Began its initial public offering (IPO) today, Friday, February 20. The company, a provider of In Vitro Fertilisation (IVF) treatments, is seeking to raise Rs 165 crore from the primary market through this offering.

IPO Details and Grey Market Premium

Prior to the launch, the Gaudium IVF IPO was trading with a grey market premium (GMP) of Rs 8.5 per share, according to InvestorGain. This suggests a potential listing price of Rs 87.5 apiece, based on the upper limit of the IPO price band of Rs 79. The GMP indicates a possible listing gain of 10.76% per share.

Note: GMP does not represent official data and is based on speculation.

Offer Size and Investment Details

The Gaudium IVF IPO consists of a fresh issue of 1.14 crore shares, amounting to Rs 90 crore, and an offer-for-sale (OFS) of 95 lakh shares, totaling Rs 75 crore. The price band for the Rs 165-crore book-building issue has been set between Rs 75 and Rs 79 per share.

Did You Know? Gaudium IVF and Women Health was incorporated in 2015 and currently operates across 30 locations in India.

Investors can apply for a minimum of 189 shares, requiring an investment of at least Rs 14,931 at the upper end of the price band. Small Non-Institutional Investors (NIIs) must apply for at least 14 lots (2,646 shares), with a minimum investment of Rs 2,09,034. Larger NIIs require a minimum application size of 67 lots (12,663 shares), totaling Rs 10,00,377.

Key Dates and Listing Information

The IPO subscription period is open until February 24. Share allotment is scheduled for February 25, with refunds initiated on the same day. Shares are expected to be transferred to allottees’ demat accounts on February 26. The tentative listing date for the Gaudium IVF IPO is February 27, on both the NSE and BSE.

Sarthi Capital Advisors Pvt. Ltd. Is the book running lead manager for the IPO, and Bigshare Services Pvt. Ltd. Is serving as the registrar.

Use of IPO Funds

Gaudium IVF intends to use the funds raised through the IPO for capital expenditure related to establishing new IVF centers, repaying existing debts, and for general corporate purposes.

Expert Insight: The company’s stated intention to expand its IVF center network suggests a strategic focus on growth within the fertility services market, potentially increasing access to these treatments across India.

The company currently operates two centers in Delhi and one each in Mumbai, Ludhiana, Srinagar, Patna, and Bengaluru.

Frequently Asked Questions

What is the price band for the Gaudium IVF IPO?

The price band for the Gaudium IVF IPO has been fixed at Rs 75 to Rs 79 per share.

When will the Gaudium IVF IPO be listed?

The Gaudium IVF IPO listing date has been tentatively fixed as February 27 on the NSE and BSE.

What will the IPO funds be used for?

The company aims to utilise the IPO funds for capital expenditure toward the establishment of new IVF centres, repayment of debts and general corporate purposes.

As Gaudium IVF and Women Health Ltd. Moves forward with its public offering, what impact might increased access to IVF treatments have on families across India?